Dear John,

Join Health Affairs Tuesday, August 27, for a virtual Journal Club event examining the costs of allowing Medicare coverage of anti-obesity medicines.

This event is for Health Affairs Insiders only.

Become an Insider today to stay up-to-date on what health care experts are thinking and talking about.

Today's Featured Articles

2023 Data From The Independent Dispute Resolution Process: Select Providers Win Big

Jack Hoadley et al.

part of our Provider Prices In The Commercial Sector series

Disability Mortality Disparity: Risk Of Mortality For Disabled Adults Nearly Twice That For Nondisabled Adults, 2008–19

Scott D. Landes

More on Private Equity

Protecting Patients And Society In An Era Of Private Equity Provider Ownership: Challenges And Opportunities For Policy

Christopher Cai and Zirui Song (May 2024)

Private Equity–Acquired Physician Practices And Market Penetration Increased Substantially, 2012–21

Ola Abdelhadi et al. (March 2024)

A Health Podyssey: Christopher Cai on Responding To Challenges Posed By Private Equity (May 2024)

Health Affairs Branded Post:

New evidence on Remote Foot Temperature Monitoring (RTM): What does a recent VHA study really tell us about the impact?

Jon Bloom, MD, CEO and Co-Founder

Sponsored by Podimetrics

Last week, Health Affairs published two ahead-of-print articles focusing on the Medicare Savings Programs and prescription drug costs.

Check them out below before the release of our September issue on access to care, coverage, and more.

Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations

Laura Tollen

Expanding Medicare Coverage Of Anti-Obesity Medicines Could Increase Annual Spending By $3.1 Billion To $6.1 Billion

Benedic Ippolito and Joseph F. Levy